Brain Metastasis Program @ MSK

Multidisciplinary #brainmet care. Unrelenting foci: pt outcomes, innovation, education, defining future treatments 2126395837 @MSKNeurosurgery @sloan_kettering

[Brain Metastasis Program @ MSK @BrainMets_MSK]

Attn all interested clinicians/scientists: Save the date for 2nd Annual #BrainMets Advanced Therapeutics Symposium: * 3/7/24 * virtual * free. Stay tuned for more on the engaging, interactive program. #btsm #lcsm #bcsm @MSKNeurosurgery @MSK_DeptOfMed @MSK_RadOnc @MSKCME

[Brandon Imber @brandon_imber]

Exciting results at #ASCO26 from the Phase III ROADS study showing outstanding brain cavity control following surgery with Cs-131 tile based brachytherapy for newly diagnosed brain metastases @Dr_N_Moss @MSKCancerCenter @MSK_RadOnc @BrainMets_MSK

[Ali Toth @AliToth_]

had the honor of presenting our study on melanoma brain metastases at #SNOASCO2025 incredibly grateful for the opportunity to present alongside so many inspiring leaders in the field! excited to keep learning & contributing in advancing care for patients @BrainMets_MSK @Dr_N_Moss

[Nelson Moss @Dr_N_Moss]

On the heels of practice-changing #DB-09 & #ASCENT-04 at #ASC025, pleased to share new review on the role of #ADCs in #brainmets, increasingly key survival determinant in pts w met cancers https://t.co/w0XlH2GC1b #bcsm #lcsm #oncoalert @MSKNeurosurgery @MSK_DeptOfMed @MSK_RadOnc

[Nelson Moss @Dr_N_Moss]

Super proud of @AliToth_ on excellent presentation @AANSNeuro @NSTumorSection & Master's eval'ing radiomic features vs multidisciplinary consensus in predicting #CNS #melanoma post-RT recurrence vs necrosis/heme. 🚨2026 nsgy applicant alert-she will match highly! @BrainMets_MSK

[Selwyn M. Vickers @DrVickersMSK]

I am pleased to share that @MSKCancerCenter’s state-of-the-art cancer care  pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center.

We are deeply grateful to Ken for his extraordinary generosity and all he has done to advance MSK’s mission of ending cancer for life.

https://t.co/R7SOrzsGqd

[The Brain Prize @BrainPrize]

Congratulations to winners of The Brain Prize 2025!
Professors @michelle_monje, @StanfordMed and @HHMINEWS Investigator, and Frank Winkler, Heidelberg University Hospital, have pioneered the field of Cancer Neuroscience. They have revealed a profound connection between cancer and the nervous system, fundamentally changing our understanding of brain tumours and potential treatments.

Learn more about the winners and their research: https://t.co/JFXwrRfmqN

#TheBrainPrize2025 #CancerNeuroscience

[Nelson Moss @Dr_N_Moss]

CNS mets=increasingly the main challenge in HER2+ #breastcancer. Here we show that fully 55% of pts w/such spread suffer CNS-related mortality; even more so in the growing (+longer-surviving) population w/CNS-only disease
https://t.co/SwFbBZu6pZ

[Brain Metastasis Program @ MSK @BrainMets_MSK]

@Dr_N_Moss @HTawbi_MD @NeuroOnc @ASCO @MSKNeurosurgery @MSK_DeptOfMed @MSKCancerCenter @SMRobertMDPhD

[Nelson Moss @Dr_N_Moss]

Energizing and inspiring #snoasco24 - congrats to @HTawbi_MD and Priya Kumthekar on a most successful #CNSmets meeting! Congrats also to Emanuela Ferraro on her #WinHER2 update @NeuroOnc @ASCO

[Memorial Sloan Kettering Radiation Oncology @MSK_RadOnc]

🧠⚡️🫁☢️New in @JCO_ASCO from @pike_lab @Chad_Rusthoven: The addition of up-front #radiation #SRS to CNS-penetrant #TKI ⬆️time-to-CNS progression & local control (but not OS) in pts with brain mets from #EGFR #ALK-driven #NSCLC #lungcancer. #lcsm #radonc
https://t.co/0QcXj1cpQf

[Memorial Sloan Kettering Radiation Oncology @MSK_RadOnc]

New by Dr @KathrynTringale @pike_lab: Small cell #lungcancer often metastasizes to the brain & has poor prognosis. This analysis of #SCLC #lcsm transcriptional factor subtypes finds differential CNS-specific outcomes & may help guide personalized care
https://t.co/rFZZT1D2lC

[Neurosurgery at Memorial Sloan Kettering @MSKNeurosurgery]

Great work from @OriBarzilai @MSKNeurosurgery and @MSKCCSpine . This is a major advance in the management of #Spine_Tumors.
Robotic Neurosurgery at MSK Speeds Recovery From Some Spinal Tumors https://t.co/LxT2OJcfUl

[Jorge Avila, MD @jorgeeavila]

Next time you are asked about prognosis in patients with #BrianMets make sure to use the GPA calculator to assess estimated survival. It’s even available on @mdcalc (for GI cancers). Great talk by Dr Sperduto

[Julia Maués @itsnot_pink]

Rare?

Leptomeningeal incidence is almost 10X that of glioblastoma.

Yet, the number of trials available for those patients is 1/3 of that for GBM.

Eye-opening slide by Dr. Priya Kumthekar from @LurieCancer.

#MSKBRAINMETSCME

[Brain Metastasis Program @ MSK @BrainMets_MSK]

Excited for tomorrow's fantastic panel on #brainmet grail: prevention & early detection. Join for insights from
🧠B. Ellingson (advanced neuro imaging)
🧠M. Hayden Gephart (liquid biopsy)
🧠A. Zimmer (chemoprevention) @aszim13
Register (complementary) at: https://t.co/IqPoI91ZYh

[Melanie Hayden Gephart @HaydenGephartMD]

Join us for an important update on the latest treatments and research in #brainmetastases.
@BrainMets_MSK @MSKNeurosurgery #MSKbrainmetsCME

https://t.co/d1hTTe6Ox8

[Brain Metastasis Program @ MSK @BrainMets_MSK]

All-⭐️ lineup discussing changing prognoses with #brainmetastases across cancers: this Thursday 3/7 - Drs Michael Postow, Sarah Goldberg, Rebecca Dent and Minesh Mehta. Register (complementary) at https://t.co/IqPoI92xNP #btsm @OncoAlert #lcsm #btsm @theABTA #medtwitter

[Brain Metastasis Program @ MSK @BrainMets_MSK]

This Thurs 3/7 @ #brainmets symposium: Expanding Reach from patient to intl scale
➡️Sperduto: integrating multimodal data
➡️Li: coalescing intl trials
➡️Budhu: advancing equity
➡️Daly: local/home care delivery
Reg today (free!): https://t.co/IqPoI91ZYh
@OncoAlert #btsm

[Brain Metastasis Program @ MSK @BrainMets_MSK]

This Thurs 3/7 @ intl #BrainMetastasis symposium: Drs Adrienne Boire, Qing Chen, Siting Gan & Peter Siegel share innovative work transforming early detection, prevention & treatment in parenchymal + leptomeningeal CNS disease➡️ reg today (no charge)! https://t.co/IqPoI91ZYh #btsm

[Brain Metastasis Program @ MSK @BrainMets_MSK]

Join the 3/7 MSK #BrainMets Symposium for updates on key clinical trials - incl. #leptomeningeal disease, targeted + immunotherapy strategies (incl TIL) & #neurosurgery trials. Virtual & complementary
🔜 https://t.co/IqPoI91ZYh
#MedTwitter #btsm #lcsm #bcsm @OncoAlert